Deerfield Management’s Erasca ERAS Stock Holding History

Deerfield Management’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-786,660	Closed	-$16.7M	–	133
2021 Q3	$16.7M	Buy	+786,660	New	+$16.2M	0.33%	75

Other funds holding ERAS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

AEPBI

AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Deerfield Management's ERAS Position: Q4 2021 in Review

Deerfield Management sold out of Erasca (ERAS) in Q4 2021, closing a stake of 786,660 shares — an estimated $16.7M sold.

Deerfield Management first reported a position in ERAS in Q3 2021 and held it in 1 quarter. The position peaked at $16.7M in Q3 2021. 63 funds tracked by Wall St. Rank hold ERAS as of Q4 2021.

Deerfield Management reported no remaining Erasca position as of Q4 2021 after selling out during the quarter.
Deerfield Management sold 786,660 Erasca shares in Q4 2021, an estimated $16.7M.
Deerfield Management first reported a position in Erasca in Q3 2021 and held it in 1 quarter.
Deerfield Management's Erasca position peaked at $16.7M in Q3 2021.
63 funds tracked by Wall St. Rank held Erasca as of Q4 2021.

Based on Deerfield Management's 13F filing for Q4 2021, filed 14 Feb 2022.